Clinical Trial Update: Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM) [NA]

View source ↗

Summary

A clinical trial evaluating ultrathin-strut biodegradable polymer sirolimus-eluting stents with P2Y12 inhibitor-based single antiplatelet therapy versus convent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Main Coronary Artery Stenosis

Drugs mentioned

• P2Y12 inhibitor-based therapy (P2Y12 inhibitor)
• Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: IGLESIAS Juan Fernando | Conditions: Left Main Coronary Artery Stenosis | NA | Status: NOT_YET_RECRUITING